CAMP HILL, Pa.--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) has completed its previously announced acquisition of Envision Pharmaceutical Services (“EnvisionRx”) from leading global private investment firm TPG and other shareholders in a transaction valued at approximately $2 billion, including approximately $1.8 billion in cash and approximately 27.9 million Rite Aid shares. “The completion of this acquisition is an important step in our strategy to expand Rite Aid’s retail healthcare platform and e
| < Prev | Next > |
|---|
